10th Annual University of California Hematologic Malignancies Consortium (UCHMC) Research Symposium

Add to Calendar 10th Annual University of California Hematologic Malignancies Consortium (UCHMC) Research Symposium 10/17/2025 8:00:00 AM 10/17/2025 5:00:00 PM America/Los_Angeles For More Details: https://uci.cloud-cme.com/course/courseoverview?EID=5166 Description: The 10th Annual UCHMC Research Symposium will include discussions regarding opportunities for collaboration across the UC system, application of novel therapies in hematologic malignancies and ongoing clinical trials currently being conducted by the UC Hematologic Malignancies Consortium. The objectives of this meeting are to gain an understanding of how basic research discoveries are being translated int... Irvine, CA false MM/DD/YYYY


Date & Location
Friday, October 17, 2025, 8:00 AM - 5:00 PM, Irvine, CA, Irvine, CA

Target Audience
Professions - Allied Health Professional, Medical Student, Non-Physician, Nurse, Nurse Practitioner, Pharmacist, Physician, Physician Assistant, Resident Physician

Credits
AMA PRA Category 1 Credits™ (6.50 hours), Non-Physician Attendance (6.50 hours)

Overview
The 10th Annual UCHMC Research Symposium will include discussions regarding opportunities for collaboration across the UC system, application of novel therapies in hematologic malignancies and ongoing clinical trials currently being conducted by the UC Hematologic Malignancies Consortium. The objectives of this meeting are to gain an understanding of how basic research discoveries are being translated into clinical trials, gain a better understanding of best practice in the management of hematologic malignancies, and to become familiar with targeted and immunotherapeutic approaches for the treatment of hematologic malignancies. Physicians, mid-level practitioners, clinical trials staff, fellows, students, basic and translational scientists are encouraged to attend and participate. We are hopeful that this meeting will help (1) patients receive effective treatments, (2) develop innovative clinical trials and (3) spur new translational laboratory investigations within the UC system.

Objectives
At the conclusion of this activity, learners will be able to:

  1. Translate how new drug discoveries in the lab can be applied in clinical trials.
  2. Design multi-center investigator initiated clinical trials based on presentations on UCHMC trials
  3. Identify the role of clinical trials in daily practice
  4. Discuss current developments in clinical care of patients with hematologic malignancies

Accreditation

University of California, Irvine School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


Additional Information

ADA Statement: In compliance with the Americans with Disabilities Act, we will make every reasonable effort to accommodate your request.  For any special requests, please contact the activity administrator before the meeting date.